Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01074528
Other study ID # SCV2010
Secondary ID
Status Completed
Phase N/A
First received February 18, 2010
Last updated July 13, 2017
Start date April 2010
Est. completion date May 2017

Study information

Verified date July 2017
Source Belgian Federal Public Service, Food Chain Safety and Environment
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose of this study is to evaluate the effects of the Mindfulness Based Stress Reduction (MBSR) training program that is offered in the investigator hospital, more specifically on quality of life, coping strategies and partner relationship by using questionnaires. To asses the possible impact of this treatment on the latter domain, partners of the patients with a cancer diagnosis are invited to join the training program.


Description:

Patients with breast cancer often experience anxiety, depression, stress and reduced quality of life. As such, there is an increased interest in the implementation of the Mindfulness-Based Stress Reduction program as an additional supportive treatment. MBSR is a structured group program that aims at reducing stress levels by enhancing awareness of the present moment in combination with a non-judgemental attitude.

The study evaluates the effects of an 8-week MBSR program on quality of life, mood, depression, stress and coping skills in breast cancer patients.

Breast cancer patients of the Breast Clinic of the Universitair Ziekenhuis Brussel participate in the MBSR program. Before and after the training program patients filled out questionnaires evaluating quality of life, coping skills, emotional functioning, stress and aspects of mindfulness.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date May 2017
Est. primary completion date April 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

For patients:

- Cancer diagnosis

- Between the age of 18 until 70

- Dutch speaking

For partners:

- between the age of 18 until 70

- dutch speaking

Exclusion Criteria:

for patients and partners:

- Ongoing radiation therapy

- Psychiatric disorders

- Previous experience with mindfulness or meditation related techniques

- Pregnancy

- No or insufficient understanding of the Dutch language

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
mindfulness based stress reduction program
8-week mindfulness training program

Locations

Country Name City State
Belgium UZ Brussel Brussel

Sponsors (1)

Lead Sponsor Collaborator
Belgian Federal Public Service, Food Chain Safety and Environment

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary quality of life (FACT) before training day 1
Primary Quality of life (FACT) after training day 48
Secondary Cancer Coping Questionnaire (CCQ) day 1
Secondary Profile Of Mood Scale (POMS) day 1
Secondary Perceived Stress Scale (PSS) day 1
Secondary Freiburg Mindfulness Scale day 1
Secondary Cancer Coping Questionnaire (CCQ) day 48
Secondary Profile of Mood Scale (POMS) day 48
Secondary Perceived Stress Scale (PSS) day 48
Secondary Freiburg Mindfulness Inventory (FMI) day48
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases